Radiological risk factors for T2-T3 glottic carcinoma treated with (chemo)radiotherapy—a multicenter analysis - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Multicenter Study on Radiological Risk Factors in T2-T3 Glottic Carcinoma Patients Undergoing (Chemo)Radiotherapy

  • By

  • Agatha S. Baidun

  • Yves M. H. F. Gorissen

  • Martine Hendriksma

  • Renske Gahrmann

  • Jose A. Hardillo

  • Sjoert Pegge

  • Robert P. Takes

  • Guido B. van den Broek

  • Martin A. de Jong

  • Federica Lucev

  • Elisabeth V. Sjogren

  • Berit M. Verbist

  • June 19, 2026

Share

Clinical Report: Radiological Risk Factors in T2-T3 Glottic Carcinoma Patients

Overview

This multicenter study investigates radiological risk factors associated with radiation failure in T2-T3 glottic carcinoma patients undergoing (chemo)radiotherapy.

Background

The management of T2-T3 glottic carcinoma is complex due to the intricate anatomy of the larynx and varying tumor spread patterns. This study aims to clarify the effectiveness of (C)RT compared to surgical options in high-risk tumor sub-localizations.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • Identified vertical anterior commissure involvement as a predictive factor for radiation failure.
  • Horizontal anterior commissure involvement and deep vocal muscle infiltration showed non-significant trends toward poorer outcomes.
  • Patients with surgical risk factors may not necessarily have better outcomes with conservative treatment.
  • Understanding tumor behavior is essential for adequate treatment comparison and patient counseling.
  • Current TNM system inconsistencies may impact treatment and follow-up strategies.

Clinical Implications

Clinicians should evaluate radiological characteristics in T2-T3 glottic carcinoma patients to identify those at higher risk for radiation failure.

Conclusion

The study emphasizes the need for further investigation into the predictors of radiation failure in glottic carcinoma.

Related Resources & Content

  1. Gastric Cancer, Impact of Adjuvant Chemoradiotherapy on Survival Outcomes in Gastric Cancer Patients Undergoing D2 Lymphadenectomy, 2012
  2. Journal of Gastroenterology, Incidence of Additional Primary Cancers in Patients with Clinical T1bN0 Esophageal Squamous Cell Carcinoma Following Definitive Treatment, 2022
  3. Journal of Neuro-Oncology, Association of Low Tumor Burden with Post-Surgical Observation in Patients with Grade 2 Astrocytomas and Oligodendrogliomas, 2025
  4. Comparison of Neoadjuvant Chemoradiotherapy Regimens Using Cisplatin/5-Fluorouracil or Carboplatin/Paclitaxel in Resectable Esophageal and Gastroesophageal Junction Cancer, 2023
  5. Laryngeal Cancer Treatment (PDQ®) - NCI, 2025
  6. Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal Cancer, NEJM, 1991
  7. Diagnostic value, sensitivity and specificity of CT, MRI, and PET in evaluation of cartilage invasion in laryngeal and hypopharyngeal cancer, Scientific Reports, 2025
  8. Laryngeal Cancer Treatment (PDQ®) - NCI
  9. Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal Cancer | New England Journal of Medicine
  10. Diagnostic value, sensitivity and specificity of CT, MRI, and PET in evaluation of cartilage invasion in laryngeal and hypopharyngeal cancer | Scientific Reports

Original Source(s)

Related Content